Furthermore, we explore how the ATX-LPA pathway impacts obesity and obesity-associated disorders, including impaired glucose homeostasis, insulin resistance, and cardiovascular disease. Here, ENPP2 is linked to obesity due to melanocortin 4 receptor deficiency.